LUPIN LTD will leap into profits soon
This scrip at Rs 1461 has crossed 20D EMA on daily charts with good volumes for past few days and is poised to cross Rs 1480 on 20W EMA after which it can leap ahead.
Scrip has bottomed out, issues with USFDA resolved, acquisition made earlier bearing fruits from oncoming quarters, debt then reducing, and its sound aggressive management holding substantial stake, it should reward patient share holders adequately now.
Buy with a stoploss of Rs 1440 or so.
Scrip has bottomed out, issues with USFDA resolved, acquisition made earlier bearing fruits from oncoming quarters, debt then reducing, and its sound aggressive management holding substantial stake, it should reward patient share holders adequately now.
Buy with a stoploss of Rs 1440 or so.
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.